Second Medical Use in Turkey | Zendy

Ezgi Baklaci | Zendy; Merve Altınay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Second Medical Use in Turkey

Author(s) -

Ezgi Baklaci,

Merve Altınay

Publication year - 2016

Publication title -

pharmaceutical patent analyst

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.247

H-Index - 15

eISSN - 2046-8962

pISSN - 2046-8954

DOI - 10.4155/ppa-2016-0011

Subject(s) - turkish , scope (computer science) , decree , appeal , legislation , treaty , law , patent law , european patent office , convention , business , political science , intellectual property , computer science , philosophy , linguistics , programming language

Turkish patent legislation complies with European Patent Convention (EPC) 1973 and EPC 2000, but does not have a corresponding provision. This triggers a debate in Turkish Law, where no regulations address protection of second (or subsequent) use. Turkish validations of European patents concerning second medical uses that have been granted within the scope of EPC 2000. However, the approach to national patent applications and patents entered to Turkey through Patent Cooperation Treaty is still questionable since the Patent Decree Law is not offering an explicit protection to second medical use and European Board of Appeal decisions (especially G5/83) are not binding for Turkish authorities. This article overviews the current approach of the Turkish legal system to second medical use patents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research